BEND2 (protein): Difference between revisions

Jump to navigation Jump to search
m (Bot: HTTP→HTTPS)
 
imported>Natureium
(in parent cat)
 
Line 1: Line 1:
'''BEND2''' is a [[protein]] that in humans is encoded by the BEND2 [[gene]].<ref name=":1">{{Cite web|url=https://www.ncbi.nlm.nih.gov/gene/?term=CXorf20|title=BEND2 BEN domain containing 2 [Homo sapiens (human)] - Gene - NCBI|website=www.ncbi.nlm.nih.gov|access-date=2017-02-03}}</ref> It is also found in other [[vertebrate]]s, including mammals, birds, and reptiles.<ref name=":1" /> The expression of BEND2 in ''[[Homo sapiens]]'' is regulated and occurs at high levels in the skeletal muscle tissue of the male [[Testicle|testis]] and in the [[bone marrow]].<ref name=":3">{{Cite web|url=https://www.ncbi.nlm.nih.gov/ieb/research/acembly/av.cgi?db=human&term=BEND2&submit=Go|title=AceView: Gene:BEND2, a comprehensive annotation of human, mouse and worm genes with mRNAs or ESTsAceView.|last=mieg@ncbi.nlm.nih.gov|first=Danielle Thierry-Mieg and Jean Thierry-Mieg,  NCBI/NLM/NIH,|website=www.ncbi.nlm.nih.gov|access-date=2017-02-03}}</ref><ref name=":0">{{Cite web|url=http://genatlas.medecine.univ-paris5.fr/fiche.php?n=34161|title=Genatlas sheet|website=genatlas.medecine.univ-paris5.fr|access-date=2017-02-03}}</ref><ref>{{Cite web|url=https://www.ncbi.nlm.nih.gov/UniGene/clust.cgi?UGID=218185&TAXID=9606&SEARCH=BEND2|title=BEN domain containing 2 (BEND2)|website=www.ncbi.nlm.nih.gov|access-date=2017-02-03}}</ref> The presence of the BEN domains in the BEND2 protein indicates that this protein may be involved in [[Chromatin remodeling|chromatin modification]] and regulation.<ref name=":6" />
{{Infobox gene}}
'''BEND2''' is a [[protein]] that in humans is encoded by the ''BEND2'' [[gene]].<ref name=":1">{{Cite web|url=https://www.ncbi.nlm.nih.gov/gene/?term=CXorf20|title=BEND2 BEN domain containing 2 [Homo sapiens (human)] - Gene - NCBI|website=www.ncbi.nlm.nih.gov|access-date=2017-02-03}}</ref> It is also found in other [[vertebrate]]s, including mammals, birds, and reptiles.<ref name=":1" /> The expression of BEND2 in ''[[Homo sapiens]]'' is regulated and occurs at high levels in the skeletal muscle tissue of the male [[Testicle|testis]] and in the [[bone marrow]].<ref name=":3">{{Cite web|url=https://www.ncbi.nlm.nih.gov/ieb/research/acembly/av.cgi?db=human&term=BEND2&submit=Go|title=AceView: Gene:BEND2, a comprehensive annotation of human, mouse and worm genes with mRNAs or ESTsAceView.|last=mieg@ncbi.nlm.nih.gov|first=Danielle Thierry-Mieg and Jean Thierry-Mieg,  NCBI/NLM/NIH,|website=www.ncbi.nlm.nih.gov|access-date=2017-02-03}}</ref><ref name=":0">{{Cite web|url=http://genatlas.medecine.univ-paris5.fr/fiche.php?n=34161|title=Genatlas sheet|website=genatlas.medecine.univ-paris5.fr|access-date=2017-02-03}}</ref><ref>{{Cite web|url=https://www.ncbi.nlm.nih.gov/UniGene/clust.cgi?UGID=218185&TAXID=9606&SEARCH=BEND2|title=BEN domain containing 2 (BEND2)|website=www.ncbi.nlm.nih.gov|access-date=2017-02-03}}</ref> The presence of the BEN domains in the BEND2 protein indicates that this protein may be involved in [[Chromatin remodeling|chromatin modification]] and regulation.<ref name=":6" />


== Gene ==
== Gene ==


=== Common aliases ===
=== Common aliases ===
BEND2 stands for BEN domain containing 2 and is also known as CXorf20 (HGNC ID: [http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=28509 28509]).<ref name=":1" /><ref>{{Cite web|url=http://www.genenames.org/cgi-bin/gene_symbol_report?q=data/hgnc_data.php&hgnc_id=28509|title=BEND2 Symbol Report {{!}} HUGO Gene Nomenclature Committee|website=www.genenames.org|access-date=2017-02-03}}</ref><ref name=":2">{{Cite web|url=http://www.genecards.org/cgi-bin/carddisp.pl?gene=BEND2|title=BEND2 Gene - GeneCards {{!}} BEND2 Protein {{!}} BEND2 Antibody|last=Database|first=GeneCards Human Gene|website=www.genecards.org|access-date=2017-02-03}}</ref>
BEND2 stands for BEN domain containing 2 and is also known as CXorf20 (HGNC ID: [https://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=28509 28509]).<ref name=":1" /><ref>{{Cite web|url=https://www.genenames.org/cgi-bin/gene_symbol_report?q=data/hgnc_data.php&hgnc_id=28509|title=BEND2 Symbol Report {{!}} HUGO Gene Nomenclature Committee|website=www.genenames.org|access-date=2017-02-03}}</ref><ref name=":2">{{Cite web|url=https://www.genecards.org/cgi-bin/carddisp.pl?gene=BEND2|title=BEND2 Gene - GeneCards {{!}} BEND2 Protein {{!}} BEND2 Antibody|last=Database|first=GeneCards Human Gene|website=www.genecards.org|access-date=2017-02-03}}</ref>


=== Locus and size ===
=== Locus and size ===
Line 19: Line 20:


== Protein (Isoform 1) ==
== Protein (Isoform 1) ==
[[File:Annotated BEND2 I-TASSER.png|thumb|Annotated image of the tertiary and secondary structure of BEND2 based on I-TASSER prediction.<ref name="J Yang, R Yan 2015">J Yang, R Yan, A Roy, D Xu, J Poisson, Y Zhang. The I-TASSER Suite: Protein structure and function prediction. Nature Methods, 12: 7-8 (2015). (Download the PDF file); A Roy, A Kucukural, Y Zhang. I-TASSER: a unified platform for automated protein structure and function prediction. Nature Protocols, 5: 725-738 (2010) (download the PDF file); Y Zhang. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics, vol 9, 40 (2008)</ref>|300x300px]]
[[File:Annotated BEND2 I-TASSER.png|thumb|Annotated image of the tertiary and secondary structure of BEND2 based on I-TASSER prediction.<ref name="J Yang, R Yan 2015">{{cite journal | vauthors = Roy A, Kucukural A, Zhang Y | title = I-TASSER: a unified platform for automated protein structure and function prediction | journal = Nature Protocols | volume = 5 | issue = 4 | pages = 725–38 | date = April 2010 | pmid = 20360767 | pmc = 2849174 | doi = 10.1038/nprot.2010.5 }}</ref>|300x300px]]


=== Molecular weight and internal composition ===
=== Molecular weight and internal composition ===
Line 32: Line 33:


=== Subcellular location ===
=== Subcellular location ===
The presence of [[Nuclear localization sequence|nuclear localization signals]] within the amino acid sequence or [[Protein primary structure|primary structure]] of the BEND2 protein leads to a prediction of [[subcellular localization]] in the nucleus.<ref name=":4">{{Cite web|url=http://www.genscript.com/psort.html|title=PSORT: Protein Subcellular Localization Prediction Too|last=|first=|date=24 November 1999|website=GenScript|archive-url=|archive-date=|dead-url=|access-date=}}</ref> The pat7 [(P-X(1-3)-(3-4K/R)] signal and a nuclear bipartite signal are both found near the N-terminus of the protein.<ref name=":4" /><ref>{{Cite journal|last=Boisvert|first=Maude|last2=Bouchard-Lévesque|first2=Véronique|last3=Fernandes|first3=Sandra|last4=Tijssen|first4=Peter|date=2014-10-01|title=Classic nuclear localization signals and a novel nuclear localization motif are required for nuclear transport of porcine parvovirus capsid proteins|journal=Journal of Virology|volume=88|issue=20|pages=11748–11759|doi=10.1128/JVI.01717-14|issn=1098-5514|pmc=4178750|pmid=25078698}}</ref>
The presence of [[Nuclear localization sequence|nuclear localization signals]] within the amino acid sequence or [[Protein primary structure|primary structure]] of the BEND2 protein leads to a prediction of [[subcellular localization]] in the nucleus.<ref name=":4">{{Cite web|url=http://www.genscript.com/psort.html|title=PSORT: Protein Subcellular Localization Prediction Too|last=|first=|date=24 November 1999|website=GenScript|archive-url=|archive-date=|dead-url=|access-date=}}</ref> The pat7 [(P-X(1-3)-(3-4K/R)] signal and a nuclear bipartite signal are both found near the N-terminus of the protein.<ref name=":4" /><ref>{{cite journal | vauthors = Boisvert M, Bouchard-Lévesque V, Fernandes S, Tijssen P | title = Classic nuclear localization signals and a novel nuclear localization motif are required for nuclear transport of porcine parvovirus capsid proteins | journal = Journal of Virology | volume = 88 | issue = 20 | pages = 11748–59 | date = October 2014 | pmid = 25078698 | pmc = 4178750 | doi = 10.1128/JVI.01717-14 }}</ref>
[[File:BEND2 Diagram.png|thumb|Post-translational modifications of BEND2. Grey diamonds indicate glycation and red diamonds show SUMOlation sites. N-terminus acetylation and SUMO interactions sites are marked at the front of the protein. Two nuclear localization signals at the same site near a domain of unknown function (Unk).  |250x250px]]
[[File:BEND2 Diagram.png|thumb|Post-translational modifications of BEND2. Grey diamonds indicate glycation and red diamonds show SUMOlation sites. N-terminus acetylation and SUMO interactions sites are marked at the front of the protein. Two nuclear localization signals at the same site near a domain of unknown function (Unk).  |250x250px]]


Line 50: Line 51:
|-
|-
|Two-hybrid screen
|Two-hybrid screen
|Ataxin 1([[Ataxin 1|ATXN1]])<ref>{{Cite journal|last=Lim|first=Janghoo|last2=Hao|first2=Tong|last3=Shaw|first3=Chad|last4=Patel|first4=Akash J.|last5=Szabó|first5=Gábor|last6=Rual|first6=Jean-François|last7=Fisk|first7=C. Joseph|last8=Li|first8=Ning|last9=Smolyar|first9=Alex|date=2006-05-19|title=A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration|journal=Cell|volume=125|issue=4|pages=801–814|doi=10.1016/j.cell.2006.03.032|issn=0092-8674|pmid=16713569}}</ref>
|Ataxin 1([[Ataxin 1|ATXN1]])<ref>{{cite journal | vauthors = Lim J, Hao T, Shaw C, Patel AJ, Szabó G, Rual JF, Fisk CJ, Li N, Smolyar A, Hill DE, Barabási AL, Vidal M, Zoghbi HY | display-authors = 6 | title = A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration | journal = Cell | volume = 125 | issue = 4 | pages = 801–14 | date = May 2006 | pmid = 16713569 | doi = 10.1016/j.cell.2006.03.032 }}</ref>
|Chromatin-binding factor; RNA metabolism
|Chromatin-binding factor; RNA metabolism
|[[Spinocerebellar ataxia|Spinocerebellar ataxia 1]]/spinocerebellar degeneration
|[[Spinocerebellar ataxia|Spinocerebellar ataxia 1]]/spinocerebellar degeneration
Line 70: Line 71:
|-
|-
|Pull down assay
|Pull down assay
|Amyolid precursor protein [[Amyloid precursor protein|(APP]])<ref>{{Cite journal|last=Oláh|first=Judit|last2=Vincze|first2=Orsolya|last3=Virók|first3=Dezső|last4=Simon|first4=Dóra|last5=Bozsó|first5=Zsolt|last6=Tőkési|first6=Natália|last7=Horváth|first7=István|last8=Hlavanda|first8=Emma|last9=Kovács|first9=János|date=2011-09-30|title=Interactions of Pathological Hallmark Proteins TUBULIN POLYMERIZATION PROMOTING PROTEIN/p25, β-AMYLOID, AND α-SYNUCLEIN|url=http://www.jbc.org/content/286/39/34088|journal=Journal of Biological Chemistry|language=en|volume=286|issue=39|pages=34088–34100|doi=10.1074/jbc.M111.243907|issn=0021-9258|pmc=3190826|pmid=21832049}}</ref>
|Amyolid precursor protein [[Amyloid precursor protein|(APP]])<ref>{{cite journal | vauthors = Oláh J, Vincze O, Virók D, Simon D, Bozsó Z, Tõkési N, Horváth I, Hlavanda E, Kovács J, Magyar A, Szũcs M, Orosz F, Penke B, Ovádi J | display-authors = 6 | title = Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein | journal = The Journal of Biological Chemistry | volume = 286 | issue = 39 | pages = 34088–100 | date = September 2011 | pmid = 21832049 | pmc = 3190826 | doi = 10.1074/jbc.M111.243907 | url = http://www.jbc.org/content/286/39/34088 }}</ref>
|[[Cell surface receptor]] in neurons; cleaved to form [[Activator (genetics)|transcriptional activators]]
|[[Cell surface receptor]] in neurons; cleaved to form [[Activator (genetics)|transcriptional activators]]
|[[Cerebral amyloid angiopathy]]; [[Alzheimer's disease]]
|[[Cerebral amyloid angiopathy]]; [[Alzheimer's disease]]
Line 77: Line 78:


== BEN Domains (protein feature) ==
== BEN Domains (protein feature) ==
BEND2 has two BEN domains at its C-terminus.<ref name=":1" /> [[BEN domain]]s are found in a diverse array of proteins and are predicted to be important for [[chromatin remodeling]] as well as for the recruitment of chromatin-modifying factors utilized during the process of [[transcriptional regulation]] of gene expression.<ref name=":6">{{Cite web|url=https://www.ebi.ac.uk/interpro/entry/IPR018379|title=BEN domain (IPR018379) < InterPro < EMBL-EBI|last=EMBL-EBI|first=InterPro|website=www.ebi.ac.uk|language=en|access-date=2017-02-03}}</ref>  BEN domains are predicted to form four [[Alpha helix|alpha helices]] that allow this domain to interact with its DNA target.<ref name=":6" /><ref name=":8">{{Cite journal|last=Dai|first=Qi|last2=Ren|first2=Aiming|last3=Westholm|first3=Jakub O.|last4=Serganov|first4=Artem A.|last5=Patel|first5=Dinshaw J.|last6=Lai|first6=Eric C.|date=2013-03-15|title=The BEN domain is a novel sequence-specific DNA-binding domain conserved in neural transcriptional repressors|url=http://genesdev.cshlp.org/content/27/6/602|journal=Genes & Development|language=en|volume=27|issue=6|pages=602–614|doi=10.1101/gad.213314.113|issn=0890-9369|pmc=3613608|pmid=23468431}}</ref>
BEND2 has two BEN domains at its C-terminus.<ref name=":1" /> [[BEN domain]]s are found in a diverse array of proteins and are predicted to be important for [[chromatin remodeling]] as well as for the recruitment of chromatin-modifying factors utilized during the process of [[transcriptional regulation]] of gene expression.<ref name=":6">{{Cite web|url=https://www.ebi.ac.uk/interpro/entry/IPR018379|title=BEN domain (IPR018379) < InterPro < EMBL-EBI|last=EMBL-EBI|first=InterPro|website=www.ebi.ac.uk|language=en|access-date=2017-02-03}}</ref>  BEN domains are predicted to form four [[Alpha helix|alpha helices]] that allow this domain to interact with its DNA target.<ref name=":6" /><ref name=":8">{{cite journal | vauthors = Dai Q, Ren A, Westholm JO, Serganov AA, Patel DJ, Lai EC | title = The BEN domain is a novel sequence-specific DNA-binding domain conserved in neural transcriptional repressors | journal = Genes & Development | volume = 27 | issue = 6 | pages = 602–14 | date = March 2013 | pmid = 23468431 | pmc = 3613608 | doi = 10.1101/gad.213314.113 | url = http://genesdev.cshlp.org/content/27/6/602 }}</ref>


[https://www.ncbi.nlm.nih.gov/pubmed/23468431 Dai et al. 2013] showed that the ''[[Drosophila melanogaster]]'' Insensitive (Insv) gene and corresponding protein has no domains of known chemical function yet it contains a single BEN domain. They illustrated the activity of the Insv protein in transcriptional regulation of genes and obtained a crystal structure of two Insv BEN domains interacting with their DNA target site.<ref name=":8" />
[https://www.ncbi.nlm.nih.gov/pubmed/23468431 Dai et al. 2013] showed that the ''[[Drosophila melanogaster]]'' Insensitive (Insv) gene and corresponding protein has no domains of known chemical function yet it contains a single BEN domain. They illustrated the activity of the Insv protein in transcriptional regulation of genes and obtained a crystal structure of two Insv BEN domains interacting with their DNA target site.<ref name=":8" />
Line 96: Line 97:


=== BEN-domain containing gene family ===
=== BEN-domain containing gene family ===
The BEND2 gene belongs to a family of human genes known as [http://www.genenames.org/cgi-bin/genefamilies/set/422 "BEN-domain containing”]. This includes [[BANP]] (BEND1), BEND3, BEND4, BEND5, BEND6, BEND7, [[NACC1 (gene)|NACC1]] (BEND8), and NACC2 (BEND9). The loci for these genes are spread throughout the human genome.<ref>{{Cite web|url=http://www.genenames.org/cgi-bin/genefamilies/set/422|title=BEN domain containing (BEND) Gene Family {{!}} HUGO Gene Nomenclature Committee|website=www.genenames.org|access-date=2017-02-21}}</ref> Each of these genes contains between one and four BEN domains. Except for at these motifs, the genes of the BEN family do not have similar sequences.
The BEND2 gene belongs to a family of human genes known as [https://www.genenames.org/cgi-bin/genefamilies/set/422 "BEN-domain containing”]. This includes [[BANP]] (BEND1), BEND3, BEND4, BEND5, BEND6, BEND7, [[NACC1 (gene)|NACC1]] (BEND8), and NACC2 (BEND9). The loci for these genes are spread throughout the human genome.<ref>{{Cite web|url=https://www.genenames.org/cgi-bin/genefamilies/set/422|title=BEN domain containing (BEND) Gene Family {{!}} HUGO Gene Nomenclature Committee|website=www.genenames.org|access-date=2017-02-21}}</ref> Each of these genes contains between one and four BEN domains. Except for at these motifs, the genes of the BEN family do not have similar sequences.


=== Orthologs ===
=== Orthologs ===
Line 304: Line 305:


== Clinical significance ==
== Clinical significance ==
Interestingly, the diseases that have been linked to BEND2 are related to the [[central nervous system]] (CNS) though expression of the gene is not highly observed in these tissues.  
The diseases that have been linked to BEND2 are related to the [[central nervous system]] though expression of the gene is not highly observed in these tissues.  
* BEND2 was identified as one of the genes that causes a CNS [[primitive neuroectodermal tumor]] when fused with the [[MN1 (gene)|MN1 gene]], which is located on [[Chromosome 22 (human)|chromosome 22]].<ref>{{Cite book|url=https://www.ncbi.nlm.nih.gov/books/NBK374260/|title=PDQ Cancer Information Summaries|last=PDQ Pediatric Treatment Editorial Board|date=2002-01-01|publisher=National Cancer Institute (US)|location=Bethesda (MD)|pmid=27466641}}</ref><ref>{{Cite journal|last=Sturm|first=Dominik|last2=Orr|first2=Brent A.|last3=Toprak|first3=Umut H.|last4=Hovestadt|first4=Volker|last5=Jones|first5=David T.W.|last6=Capper|first6=David|last7=Sill|first7=Martin|last8=Buchhalter|first8=Ivo|last9=Northcott|first9=Paul A.|date=2016-02-25|title=New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs|url=http://linkinghub.elsevier.com/retrieve/pii/S0092867416000556|journal=Cell|language=English|volume=164|issue=5|pages=1060–1072|doi=10.1016/j.cell.2016.01.015|issn=0092-8674|pmc=5139621|pmid=26919435}}</ref>
* BEND2 was identified as one of the genes that causes a central nervous system [[primitive neuroectodermal tumor]] when fused with the [[MN1 (gene)|MN1 gene]], which is located on [[Chromosome 22 (human)|chromosome 22]].<ref>{{Cite book|url=https://www.ncbi.nlm.nih.gov/books/NBK374260/|title=PDQ Cancer Information Summaries|last=PDQ Pediatric Treatment Editorial Board|date=2002-01-01|publisher=National Cancer Institute (US)|location=Bethesda (MD)|pmid=27466641}}</ref><ref>{{cite journal | vauthors = Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DT, Capper D, Sill M, Buchhalter I, Northcott PA, Leis I, Ryzhova M, Koelsche C, Pfaff E, Allen SJ, Balasubramanian G, Worst BC, Pajtler KW, Brabetz S, Johann PD, Sahm F, Reimand J, Mackay A, Carvalho DM, Remke M, Phillips JJ, Perry A, Cowdrey C, Drissi R, Fouladi M, Giangaspero F, Łastowska M, Grajkowska W, Scheurlen W, Pietsch T, Hagel C, Gojo J, Lötsch D, Berger W, Slavc I, Haberler C, Jouvet A, Holm S, Hofer S, Prinz M, Keohane C, Fried I, Mawrin C, Scheie D, Mobley BC, Schniederjan MJ, Santi M, Buccoliero AM, Dahiya S, Kramm CM, von Bueren AO, von Hoff K, Rutkowski S, Herold-Mende C, Frühwald MC, Milde T, Hasselblatt M, Wesseling P, Rößler J, Schüller U, Ebinger M, Schittenhelm J, Frank S, Grobholz R, Vajtai I, Hans V, Schneppenheim R, Zitterbart K, Collins VP, Aronica E, Varlet P, Puget S, Dufour C, Grill J, Figarella-Branger D, Wolter M, Schuhmann MU, Shalaby T, Grotzer M, van Meter T, Monoranu CM, Felsberg J, Reifenberger G, Snuderl M, Forrester LA, Koster J, Versteeg R, Volckmann R, van Sluis P, Wolf S, Mikkelsen T, Gajjar A, Aldape K, Moore AS, Taylor MD, Jones C, Jabado N, Karajannis MA, Eils R, Schlesner M, Lichter P, von Deimling A, Pfister SM, Ellison DW, Korshunov A, Kool M | display-authors = 6 | title = New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs | language = English | journal = Cell | volume = 164 | issue = 5 | pages = 1060–1072 | date = February 2016 | pmid = 26919435 | pmc = 5139621 | doi = 10.1016/j.cell.2016.01.015 | url = http://linkinghub.elsevier.com/retrieve/pii/S0092867416000556 }}</ref>
* A rare primary CNS [[Lymphoma|lymphoma tumor]] was found to have a high mutation ratio for BEND2; however, the authors do not describe this gene as primarily responsible for the tumor.<ref>{{Cite journal|last=Fukumura|first=Kazutaka|last2=Kawazu|first2=Masahito|last3=Kojima|first3=Shinya|last4=Ueno|first4=Toshihide|last5=Sai|first5=Eirin|last6=Soda|first6=Manabu|last7=Ueda|first7=Hiroki|last8=Yasuda|first8=Takahiko|last9=Yamaguchi|first9=Hiroyuki|date=2016-06-01|title=Genomic characterization of primary central nervous system lymphoma|url=https://link.springer.com/article/10.1007/s00401-016-1536-2|journal=Acta Neuropathologica|language=en|volume=131|issue=6|pages=865–875|doi=10.1007/s00401-016-1536-2|issn=0001-6322}}</ref>
* A rare primary central nervous system [[Lymphoma|lymphoma tumor]] was found to have a high mutation ratio for BEND2; however, the authors do not describe this gene as primarily responsible for the tumor.<ref>{{cite journal | vauthors = Fukumura K, Kawazu M, Kojima S, Ueno T, Sai E, Soda M, Ueda H, Yasuda T, Yamaguchi H, Lee J, Shishido-Hara Y, Sasaki A, Shirahata M, Mishima K, Ichimura K, Mukasa A, Narita Y, Saito N, Aburatani H, Nishikawa R, Nagane M, Mano H | display-authors = 6 | title = Genomic characterization of primary central nervous system lymphoma | journal = Acta Neuropathologica | volume = 131 | issue = 6 | pages = 865–75 | date = June 2016 | pmid = 26757737 | doi = 10.1007/s00401-016-1536-2 | url = https://link.springer.com/article/10.1007/s00401-016-1536-2 }}</ref>
* A young girl diagnosed with severe [[Epilepsy-intellectual disability in females|epileptic encephalopathy]] was found to have a 300-kb [[Deletion (genetics)|deletion]] in a region that included BEND2, an extremely rare [[mutation]] not found in her parents’ [[genome]]s.<ref>{{Cite journal|last=Bahi-Buisson|first=Nadia|last2=Girard|first2=Benoit|last3=Gautier|first3=Agnes|last4=Nectoux|first4=Juliette|last5=Fichou|first5=Yann|last6=Saillour|first6=Yoann|last7=Poirier|first7=Karine|last8=Chelly|first8=Jamel|last9=Bienvenu|first9=Thierry|date=2010-01-01|title=Epileptic encephalopathy in a girl with an interstitial deletion of Xp22 comprising promoter and exon 1 of the CDKL5 gene|url=http://onlinelibrary.wiley.com/doi/10.1002/ajmg.b.30974/abstract|journal=American Journal of Medical Genetics Part B|language=en|volume=153B|issue=1|pages=202–207|doi=10.1002/ajmg.b.30974|issn=1552-485X}}</ref>
* A young girl diagnosed with severe [[Epilepsy-intellectual disability in females|epileptic encephalopathy]] was found to have a 300-kb [[Deletion (genetics)|deletion]] in a region that included BEND2, an extremely rare [[mutation]] not found in her parents’ [[genome]]s.<ref>{{cite journal | vauthors = Bahi-Buisson N, Girard B, Gautier A, Nectoux J, Fichou Y, Saillour Y, Poirier K, Chelly J, Bienvenu T | display-authors = 6 | title = Epileptic encephalopathy in a girl with an interstitial deletion of Xp22 comprising promoter and exon 1 of the CDKL5 gene | journal = American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics | volume = 153B | issue = 1 | pages = 202–7 | date = January 2010 | pmid = 19455595 | doi = 10.1002/ajmg.b.30974 | url = http://onlinelibrary.wiley.com/doi/10.1002/ajmg.b.30974/abstract }}</ref>
* An individual with [[Autism spectrum|adult autism]] was identified to have a [[Copy-number variation|copy-number variant]] of unknown significance in a region only containing BEND2.<ref>{{Cite journal|last=Stobbe|first=Gary|last2=Liu|first2=Yajuan|last3=Wu|first3=Rebecca|last4=Hudgings|first4=Laura Heath|last5=Thompson|first5=Owen|last6=Hisama|first6=Fuki M.|date=2014-01-01|title=Diagnostic yield of array comparative genomic hybridization in adults with autism spectrum disorders|url=http://www.nature.com/gim/journal/v16/n1/full/gim201378a.html|journal=Genetics in Medicine|language=en|volume=16|issue=1|pages=70–77|doi=10.1038/gim.2013.78|issn=1098-3600}}</ref>
* An individual with [[Autism spectrum|adult autism]] was identified to have a [[Copy-number variation|copy-number variant]] of unknown significance in a region only containing BEND2.<ref>{{cite journal | vauthors = Stobbe G, Liu Y, Wu R, Hudgings LH, Thompson O, Hisama FM | title = Diagnostic yield of array comparative genomic hybridization in adults with autism spectrum disorders | journal = Genetics in Medicine | volume = 16 | issue = 1 | pages = 70–7 | date = January 2014 | pmid = 23765050 | doi = 10.1038/gim.2013.78 | url = http://www.nature.com/gim/journal/v16/n1/full/gim201378a.html }}</ref>


== References ==
== References ==
{{reflist}}
{{reflist}}


[[Category:Genetics]]
[[Category:Human genes]]
[[Category:Human genetics]]
[[Category:Genes on human chromosome X]]
[[Category:Genes on human chromosome X]]

Latest revision as of 01:17, 25 September 2018

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

BEND2 is a protein that in humans is encoded by the BEND2 gene.[1] It is also found in other vertebrates, including mammals, birds, and reptiles.[1] The expression of BEND2 in Homo sapiens is regulated and occurs at high levels in the skeletal muscle tissue of the male testis and in the bone marrow.[2][3][4] The presence of the BEN domains in the BEND2 protein indicates that this protein may be involved in chromatin modification and regulation.[5]

Gene

Common aliases

BEND2 stands for BEN domain containing 2 and is also known as CXorf20 (HGNC ID: 28509).[1][6][7]

Locus and size

The locus for BEND2 is on the minus strand of the X chromosome at Xp22.13. The gene is approximately 58 kilobases in length.[1]

mRNA

File:BEND2 Alternative Transcripts.png
A screenshot of the NCBI Gene page for BEND2 showing alternative splicing of the BEND2 mRNA transcript.[8] Both exons (dark rectangles) and introns are shown.

Alternative splicing

BEND2 contains 14 exons which undergo alternative splicing to create five transcript variants that vary from 4,720 base pairs (bp) to 2,144 bp in the mature mRNA.[1][7][3] The longest and most complete transcript of the gene, variant 1, encodes isoform 1 of the BEND2 protein (NP_699177.2).[1]

5' and 3'UTR

The untranslated regions (UTR) flanking the coding sequence of BEND2 at the 5' and 3' end of the mature mRNA molecule contain sites for RNA-binding proteins, including RBMX, pum2, and EIF4B as well as microRNA binding sites. The 5'UTR also contains an upstream in-frame stop codon and the 3'UTR contains a polyadenylation signal sequence.

Protein (Isoform 1)

File:Annotated BEND2 I-TASSER.png
Annotated image of the tertiary and secondary structure of BEND2 based on I-TASSER prediction.[9]

Molecular weight and internal composition

The predicted molecular weight is 87.9 kDal.[10][11]

The predicted isoelectric point is pH 5.07.[12]

The internal composition is enriched for serine residues.[10]

Isoforms

Corresponding to the five alternative transcripts of BEND2, the protein encoded by this gene is found in two isoforms (1 and 2) as well as three predicted structures (X1, X2, and X3). These isoforms range from 813 to 645 amino acids in length.[1] Isoform 1 is 799 amino acids in length.[13]

Subcellular location

The presence of nuclear localization signals within the amino acid sequence or primary structure of the BEND2 protein leads to a prediction of subcellular localization in the nucleus.[14] The pat7 [(P-X(1-3)-(3-4K/R)] signal and a nuclear bipartite signal are both found near the N-terminus of the protein.[14][15]

File:BEND2 Diagram.png
Post-translational modifications of BEND2. Grey diamonds indicate glycation and red diamonds show SUMOlation sites. N-terminus acetylation and SUMO interactions sites are marked at the front of the protein. Two nuclear localization signals at the same site near a domain of unknown function (Unk).

Structure

The secondary structure for BEND2 is unclear, in particular at the N-terminus, which is poorly conserved between orthologs. The C-terminus contains two BEN domains, which are predicted to form a series of alpha helices.[1][5]

Post-translational modifications

Based on its primary structure, BEND2 is predicted to undergo N-terminus acetylation, glycation of several lysine residues, SUMOlation, a SUMO interaction at the N-terminus, S-palmitoylation, and extensive phosphorylation.[16]

Interacting Proteins

BEND2 is found to interact with the following proteins through experimental yeast two-hybrid screens or pull down assays.

Experiment type Protein Protein Function Associated diseases
Two-hybrid screen Ataxin 1(ATXN1)[17] Chromatin-binding factor; RNA metabolism Spinocerebellar ataxia 1/spinocerebellar degeneration
Two-hybrid screen Splicing factor 3A subunit 2(SF3A2)[18] Activation of U2 snRNP; microtubule-binding protein
Two-hybrid screen LIM Homeobox 2 (LHX2)[18] Transcriptional regulator for cell differentiation; sequence-specific DNA binding Schizencephaly
Two-hybrid screen Proline Rich 20D (PRR20D)[18] Unknown function
Pull down assay Amyolid precursor protein (APP)[19] Cell surface receptor in neurons; cleaved to form transcriptional activators Cerebral amyloid angiopathy; Alzheimer's disease
File:BEN domains of D. melanogaster Insensitive proteins.png
BEN domains of two D. melanogaster Insensitive proteins with their DNA target site.[9]

BEN Domains (protein feature)

BEND2 has two BEN domains at its C-terminus.[1] BEN domains are found in a diverse array of proteins and are predicted to be important for chromatin remodeling as well as for the recruitment of chromatin-modifying factors utilized during the process of transcriptional regulation of gene expression.[5] BEN domains are predicted to form four alpha helices that allow this domain to interact with its DNA target.[5][20]

Dai et al. 2013 showed that the Drosophila melanogaster Insensitive (Insv) gene and corresponding protein has no domains of known chemical function yet it contains a single BEN domain. They illustrated the activity of the Insv protein in transcriptional regulation of genes and obtained a crystal structure of two Insv BEN domains interacting with their DNA target site.[20]

Expression

File:GDS3113 Microarray.png
NCBI GEO Profile GDS3113 / 227904 showing tissue expression data for BEND2.

Tissue expression pattern

The expression of the BEND2 gene is regulated and it is therefore not ubiquitously expressed in the human body. High expression occurs in the testis and in the bone marrow.[21] The NCBI EST profile for this gene shows expression only in the testis and in the muscle.[22]

Transcriptional regulation of expression

The promoter regulating expression of BEND2 (GXP_2567556) is 1255 base pairs in length and is located directly upstream of the BEND2 gene. It regulates transcription of all five transcriptional variants of BEND2.[23] Genomatix's MatInspector program predicted 418 transcription factor binding sites within the BEND2 promoter, including for SRY, neurogenin, interferon regulatory factor-3 (IRF-3), Ikaros2, and TCF/LEF-1.

Homology

Paralogs

The BEND2 protein has no known paralogs within the human genome.[24]

BEN-domain containing gene family

The BEND2 gene belongs to a family of human genes known as "BEN-domain containing”. This includes BANP (BEND1), BEND3, BEND4, BEND5, BEND6, BEND7, NACC1 (BEND8), and NACC2 (BEND9). The loci for these genes are spread throughout the human genome.[25] Each of these genes contains between one and four BEN domains. Except for at these motifs, the genes of the BEN family do not have similar sequences.

Orthologs

The BEND2 gene is conserved across evolutionary time as it has 114 known orthologs in a wide range of vertebrate species including mammals, birds, crocodilia, and amphibians.[26] The BEND2 protein has 42 known orthologs.[27] The C-terminus of the protein, the location of its BEN domains, is highly conserved; however, the N-terminus is not well conserved, even within the order of Primates.

Genus/species Common name Order Date of divergence from H. sapiens (mya) Accession number Sequence length Whole sequence identity C-terminus identity
Homo sapiens Human Primates 0 NP_699177.2 799 1.000 1.000
Pongo abelii Orangutan Primates 15.76 -- 784 0.921 0.854
Macaca nemestrina Southern pig-tailed macaque Primates 29.44 XP_011733709.1 823 0.694 0.828
Vicugna pacos Alpaca Artiodactyla 96 XP_015106214.1 740 0.433 0.512
Ceratotherium simum simum White rhinoceros Perissodactyla 96 XP_014646569.1 864 0.412 0.527
Loxodonta africana African bush elephant Proboscidea 105 XP_010594135.1 829 0.382 0.489
Canis lupus familiaris Dog Carnivora 96 XP_013967473.1 900 0.362 0.445
Ailuropoda melanoleuca Giant panada Carnivora 96 XP_019665441.1 852 0.353 0.460
Rhinolophus sinicus Chinese horseshoe bat Chiroptera 96 XP_019610944.1 808 0.345 0.459
Dasypus novemcinctus Nine-banded armadillo Cingulata 105 XP_012377569.1 886 0.342 0.500
Trichechus manatus latirostris Manatee Sirenia 105 XP_012412857.1 950 0.335 0.475
Chrysochloris asiatica Cape golden mole Afrosoricida 105 XP_006835746.1 683 0.330 0.443
Oryctolagus cuniculus European rabbit Lagomorpha 90 XP_017205124.1 811 0.305 0.438
Monodelphis domestica Gray short-tailed opossum Didelphimorphia 159 XP_007500895.1 728 0.303 0.443
Ornithorhynchus anatinus Platypus Monotremata 177 XP_007668655.1 715 0.302 0.429
Gavialis gangeticus Fish-eating crocodile Crocodilia 312 XP_019380828.1 697 0.309 0.458
Chelonia mydas Green sea turtle Testudines 312 XP_007070584.1 749 0.297 0.453
Apteryx australis mantelli North Island brown kiwi Apterygiformes 312 XP_013807123.1 647 0.295 0.444
Columba livia Rock dove Columbiformes 312 XP_005509980.1 668 0.287 0.442
Pygoscelis adeliae Adelie penguin Sphenisciformes 312 XP_009323754.1 657 0.282 0.458
Nanorana parkeri Tibet frog Anura 352 XP_018417228.1 586 0.260 0.376

Function

BEND2 is predicted to be a DNA-binding protein due to the presence of BEN domains at its C-terminus, a hypothesis supported by its localization to the nucleus, the transcription factors found in its promoter region, and the nature of the proteins it interacts with. Though the precise function of the BEND2 protein is not yet well understood by the scientific community, BEN domains have been found to be important regulators of transcription.[20]

Clinical significance

The diseases that have been linked to BEND2 are related to the central nervous system though expression of the gene is not highly observed in these tissues.

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 "BEND2 BEN domain containing 2 [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2017-02-03.
  2. mieg@ncbi.nlm.nih.gov, Danielle Thierry-Mieg and Jean Thierry-Mieg, NCBI/NLM/NIH,. "AceView: Gene:BEND2, a comprehensive annotation of human, mouse and worm genes with mRNAs or ESTsAceView". www.ncbi.nlm.nih.gov. Retrieved 2017-02-03.
  3. 3.0 3.1 "Genatlas sheet". genatlas.medecine.univ-paris5.fr. Retrieved 2017-02-03.
  4. "BEN domain containing 2 (BEND2)". www.ncbi.nlm.nih.gov. Retrieved 2017-02-03.
  5. 5.0 5.1 5.2 5.3 EMBL-EBI, InterPro. "BEN domain (IPR018379) < InterPro < EMBL-EBI". www.ebi.ac.uk. Retrieved 2017-02-03.
  6. "BEND2 Symbol Report | HUGO Gene Nomenclature Committee". www.genenames.org. Retrieved 2017-02-03.
  7. 7.0 7.1 Database, GeneCards Human Gene. "BEND2 Gene - GeneCards | BEND2 Protein | BEND2 Antibody". www.genecards.org. Retrieved 2017-02-03.
  8. "BEND2 BEN domain containing 2 [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2017-02-21.
  9. 9.0 9.1 Roy A, Kucukural A, Zhang Y (April 2010). "I-TASSER: a unified platform for automated protein structure and function prediction". Nature Protocols. 5 (4): 725–38. doi:10.1038/nprot.2010.5. PMC 2849174. PMID 20360767.
  10. 10.0 10.1 "Statistical analysis of protein sequence (SAPS)". SDSC Biology Workbench- Protein Tools. Retrieved 4 April 2017.
  11. "AAStats". SDSC Biology Workbench- Protein Tools. Retrieved 4 April 2017.
  12. "PI". SDSC Biology Workbench- Protein Tools. Retrieved 4 April 2017.
  13. "BEN domain-containing protein 2 isoform 1 [Homo sapiens] - Protein - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2017-02-03.
  14. 14.0 14.1 "PSORT: Protein Subcellular Localization Prediction Too". GenScript. 24 November 1999.
  15. Boisvert M, Bouchard-Lévesque V, Fernandes S, Tijssen P (October 2014). "Classic nuclear localization signals and a novel nuclear localization motif are required for nuclear transport of porcine parvovirus capsid proteins". Journal of Virology. 88 (20): 11748–59. doi:10.1128/JVI.01717-14. PMC 4178750. PMID 25078698.
  16. "NetAcet, NetPhos, GPS, GPS-Lipids, GPS-SUMOlyation, and NetGlycate". ExPASY.
  17. Lim J, Hao T, Shaw C, Patel AJ, Szabó G, Rual JF, et al. (May 2006). "A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration". Cell. 125 (4): 801–14. doi:10.1016/j.cell.2006.03.032. PMID 16713569.
  18. 18.0 18.1 18.2 "IntAct- search for BEND2". EMBL-EBI. Retrieved 19 April 2017.
  19. Oláh J, Vincze O, Virók D, Simon D, Bozsó Z, Tõkési N, et al. (September 2011). "Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein". The Journal of Biological Chemistry. 286 (39): 34088–100. doi:10.1074/jbc.M111.243907. PMC 3190826. PMID 21832049.
  20. 20.0 20.1 20.2 Dai Q, Ren A, Westholm JO, Serganov AA, Patel DJ, Lai EC (March 2013). "The BEN domain is a novel sequence-specific DNA-binding domain conserved in neural transcriptional repressors". Genes & Development. 27 (6): 602–14. doi:10.1101/gad.213314.113. PMC 3613608. PMID 23468431.
  21. "GDS3113 / 227904". www.ncbi.nlm.nih.gov. Retrieved 2017-04-25.
  22. National Center for Biotechnology Information. "EST Profile - Hs.403802". www.ncbi.nlm.nih.gov. Retrieved 2017-04-25.
  23. "ElDorado: Annotation and Analysis". Genomatix. 2017.
  24. "Human genome, search for BEND2 isoform 1 protein". BLAT.
  25. "BEN domain containing (BEND) Gene Family | HUGO Gene Nomenclature Committee". www.genenames.org. Retrieved 2017-02-21.
  26. "Homo sapiens BEN domain containing 2 (BEND2), transcript variant 1, mR - Nucleotide - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2017-02-21.
  27. "Gene: BEND2 (ENSG00000177324) - Summary - Homo sapiens - Ensembl genome browser 87". useast.ensembl.org. Retrieved 2017-02-21.
  28. PDQ Pediatric Treatment Editorial Board (2002-01-01). PDQ Cancer Information Summaries. Bethesda (MD): National Cancer Institute (US). PMID 27466641.
  29. Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DT, Capper D, et al. (February 2016). "New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs". Cell. 164 (5): 1060–1072. doi:10.1016/j.cell.2016.01.015. PMC 5139621. PMID 26919435.
  30. Fukumura K, Kawazu M, Kojima S, Ueno T, Sai E, Soda M, et al. (June 2016). "Genomic characterization of primary central nervous system lymphoma". Acta Neuropathologica. 131 (6): 865–75. doi:10.1007/s00401-016-1536-2. PMID 26757737.
  31. Bahi-Buisson N, Girard B, Gautier A, Nectoux J, Fichou Y, Saillour Y, et al. (January 2010). "Epileptic encephalopathy in a girl with an interstitial deletion of Xp22 comprising promoter and exon 1 of the CDKL5 gene". American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics. 153B (1): 202–7. doi:10.1002/ajmg.b.30974. PMID 19455595.
  32. Stobbe G, Liu Y, Wu R, Hudgings LH, Thompson O, Hisama FM (January 2014). "Diagnostic yield of array comparative genomic hybridization in adults with autism spectrum disorders". Genetics in Medicine. 16 (1): 70–7. doi:10.1038/gim.2013.78. PMID 23765050.